TBL1XR1 and nasopharyngeal carcinoma: As shown in Figure 5D, consistent with above results, after cisplatin treatment, the percentage of apoptotic cells in tumors obtained from the CNE2-TBL1XR1 group was significantly reduced in comparison with that in tumors obtained from the other group, strongly suggesting a suppressive effect of elevated TBL1XR1 on cisplatin sensitivity within the NPC cells.